A new approach for the treatment of recurrent large abdominal hernias: the overlap flap

Plastic and Reconstructive Surgery
O SensözC N Baran

Abstract

In this article we report a new technique for the treatment of recurrent large abdominal hernias and skin laxity: the overlap flap. This technique combines abdominoplasty with hernia repair. Obese patients with recurrent large abdominal hernias and skin laxity could benefit from this operation. This operation could not be performed in patients with a wide absence of the abdominal wall. A total of six patients were treated with this technique in our clinic. Follow-up of the patients has ranged from 1 to 4 years. Cosmetic results were excellent in all patients. No recurrence of the hernias has been observed in any of the patients. Two flaps are prepared; the lower one is deepithelialized, and it is used as an autogenous mesh in place of a prosthetic material to reinforce the abdominal wall, and the upper flap is prepared and overlapped on this lower one.

References

Jan 1, 1989·British Journal of Plastic Surgery·J Colville
Sep 1, 1988·British Journal of Plastic Surgery·A Uzunismail
Jul 1, 1982·British Journal of Plastic Surgery·P J Smith, S H Harrison
Apr 1, 1981·British Journal of Plastic Surgery·B Pontén
Sep 1, 1995·British Journal of Plastic Surgery·N IshikuraS Tsukada
Jun 1, 1993·British Journal of Plastic Surgery·N KaracaoglanY Türkgüven

❮ Previous
Next ❯

Citations

Mar 12, 2004·Annales de chirurgie plastique et esthétique·A-A SankaléM Ndoye
Feb 1, 2003·Plastic and Reconstructive Surgery·Omer SensözCihat Baran
Jan 31, 2006·American Journal of Surgery·Antonio Espinosa-de-Los-MonterosLuis O Vásconez
Oct 10, 2008·Chirurgie de la main·P Samson, B Salazard

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.